Company intelligence / Profile preview

Shijiazhuang Lerentang Pharmaceutical

Shijiazhuang, Hebei Province, China

Ownership: Private
Development stage: Other

Overview

LRT is a profitable pharmaceutical company specializing in modernized Chinese traditional medicines with a strong focus on pain management products. The company has 127 SFDA-approved products in its portfolio[2]. Its flagship product, Zhong Tong An Capsules, is an effective pain medicine that accounted for approximately 50% of LRT's total revenue in 2007[2].

Therapeutic areas: HematologyImmunologyOtherCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Pharma

Partnerships

China Aoxing Pharmaceutical Company, Inc. (acquirer)

Beyond the preview

Go deeper on Shijiazhuang Lerentang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shijiazhuang Lerentang Pharmaceutical.

Explore the full profile